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Abstract
In a last few decades mushrooms are increasingly attracting attention as functional food and
sources of biologically active compounds. Several Trametes species have been used for
centuries in traditional medicine of East Asia cultures, but only T. versicolor was studied suf-
ficiently while there are less substantial data about medicinal properties of other species.
Trametes versicolor, T. hirsuta and T. gibbosa were the species tested for biological activi-
ties. Antifungal potentials of extracts were assessed for clinical strains of selected Candida
and Aspergillus species. ABTS and FRAP assays were used to evaluate antioxidant capaci-
ties of studied extracts. Cytotoxic activity was determined against human cervix and lung
adenocarcinoma and colon carcinoma cell lines. Antineurodegenerative activity was
assessed by determining the rate of acetylcholinesterase and tyrosinase activity. The pres-
ence of metabolites in extracts of mycelia and basidiocarps of studied Trametes species
was analyzed by 1H NMR spectroscopy. Studied extracts showed low antifungal potential in
comparison with ketoconazole. Basidiocarp extracts were more effective ABTS+ scaven-
gers and Fe2+ reducers than mycelium ones but less effective in comparison with L-ascorbic
acid. Results showed that mycelium extracts had stronger cytotoxic effects against three
cancer cell lines than basidiocarp ones, and that cervix adenocarcinoma cells were the most
sensitive to the extracts and commercial cytostatics. T. versicolor mycelium extract was the
most effective inhibitor of acetylcholinesterase activity but double weaker than galantamine,
and T. gibbosa mycelium extract was significantly better inhibitor of tyrosinase activity than
kojic acid for 40.9%. Chemical analysis indicated strong synergistic action of triterpenes,
sugars and polyphenols in applied assays. The results suggest that tested Trametes spe-
cies have significant medicinal potentials which could be attributed to antioxidative and cyto-
toxic activity. Additionally both, basidiocarps and mycelia extracts can strongly inhibit
activity of acetylcholinesterase and tyrosinase.
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Introduction
Mushrooms have an established history of use as healthy food or for preparations in tradi-
tional medicine of both the Western and Eastern cultures, but their great pharmacological
potential is still underutilized [1]. Among nearly 60 described Trametes species just a few
are screened for their medicinal properties since records confirmed their use in traditional
Chinese medicinal practice for removing toxins, treatment of various infections, strength-
ening, energy increasing, improvement of liver and spleen function and enhancing of the
immune response [2]. Trametes versicolor (L.:Fr.) Lloyd whose folk names are Turkey Tail
(Western cultures), Yun-Zhi (China), or Kawaratake (Japan), is the most commonly used
species from the genus whose whole fruiting bodies are used for tonic or tea preparation
[2]. In Ming Dynasty edition of the Compendium of Chinese Materia Medica, more than
120 strains of T. versicolor have been recorded for their medicinal properties which were the
best manifested after chronic use [2]. Medicinal effects have been also demonstrated in con-
ventional medicine mainly in treatment of various types of cancers, infections of the respi-
ratory, urinary and digestive tracts, chronic hepatitis and rheumatoid arthritis [2, 3]. Some
reports also implied traditional usage of polypore mushroom fruiting bodies for increasing
memory and improvement of mental functions [4]. Extensive and controlled in vitro
researches also reported antiviral and antioxidant activity of polysaccharopeptides isolated
from Trametes spp. fruiting body extracts [5, 6].
All these activities are based on the production of numerous active compounds, such as two
proteoglucans (PSK and PSP), phenolic compounds, terpenoids and organic acids. PSK and
PSP are extracted from T. versicolor basidiocarps and primarily have imunostimulatory activi-
ties, i.e. induce production of interleukin-6, interferons, imunoglobuline-G, macrophages and
T-lymphocytes. However, they also posses immunosuppressive potential in chemotherapy,
radiation and blood transfusion, antiproliferative effect on various tumour cell lines based on
stimulation of superoxide dismutase and gluthation peroxidase productions, as well as antimi-
crobial, antiviral, analgetic and hepatoprotective activities [7]. Phenolic compounds as well as
linoleic acid isolated from T. lactinea are good antimicrobial, antioxidative, cytostatic and gen-
oprotective agents [6, 8, 9, 10]. Significant antibacterial effect is characteristic of sesquiterpe-
noid coriolin firstly isolated from T. consors, while ascorbic acid was shown as the main carrier
of antioxidative activity in T. versicolor [9, 11]. Since described activities might have been
responsible for medicinal effects in traditional practice the goal of this study was to elucidate
antifungal, antioxidative, cytotoxic and antineurodegenerative potential of basidiocarp and
mycelium extracts of selected Trametes species.
Materials and methods
Organisms and cultivation conditions
The basidiocarps were collected from Serbia, and identified according to the macroscopic fea-
tures and the micromorphology of the reproductive structures [12, 13] as Trametes gibbosa, T.
hirsuta and T. versicolor. Small fragment of each fresh fruiting body was extracted on Malt agar
medium (MA) for isolation of pure cultures of T. gibbosa BEOFB 310, T. hirsuta BEOFB 301
and T. versicolor BEOFB 321, which are then maintained in the Culture Collection of the Insti-
tute of Botany, Faculty of Biology, University of Belgrade (BEOFB) (Table 1). For the locations
of sampling no specific permission was required according to Serbian Law on Nature Protec-
tion (“Official Gazette of RS”, no. 36/2009, 88/2010 and 91/2010 –corr. and 14/2016). Studied
species are not endangered or protected, according to IUCN list or any other domestic and
international legislative.
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Inoculum preparation was consisted of several phases: (i) inoculation of 100.0 mL synthetic
medium (glucose– 10.0 g/L; NH4NO3−2.0 g/L; K2HPO4−1.0 g/L; NaH2PO4 × H2O – 0.4 g/L;
MgSO4 × 7H2O – 0.5 g/L; yeast extract– 2.0 g/L; pH 6.5) with 25 mycelial plugs (Ø 0.5 cm,
from 7-day-old culture on malt agar medium); (ii) incubation at room temperature (22 ± 2 ˚C)
on a rotary shaker (100 rpm) for 7 days; (iii) washing of obtained biomass with sterile distilled
water (dH2O) 3 times; (iv) homogenisation of biomass with 100.0 mL sterile dH2O in labora-
tory blender.
Mycelial biomasses of the studied species were obtained by submerged cultivation in
1000-mL flasks containing 500.0 mL of modified synthetic medium (with glucose in the con-
centration of 65.0 g/L) inoculated with 30.0 mL of homogenized inoculum, at room tempera-
ture and on a rotary shaker during 21 days.
Extraction
Dried mycelia and fruiting bodies (3.0 g) were ground to powder in laboratory blender.
Extraction was carried out in 96% ethanol (90.0 mL) on magnetic stirrer during 72 hours. The
obtained extracts were centrifuged (20 ˚C, 3000 rpm, 10 min), and supernatants filtrated
through Whatman No. 4 filter paper. The filtrates were concentrated under reduced pressure
in a rotary evaporator (Bu¨chi, Rotavapor R-114, Switzerland) at 40 ˚C to dryness, and redis-
solved in 96% ethanol (for antioxidative assay), or in 5% dimethyl sulphoxide (DMSO) (for
antifungal and anticancer assays) or in 0.1 M Na-phosphate buffer (for antineurodegenerative
potential assay) to an initial concentration of 32.0 mg/mL. The extraction yield was deter-
mined as the ratio of dry fungal biomass before extraction and dry extract weight after the
evaporation process.
Determination of antifungal activity
Antifungal potentials of basidiocarp and mycelium extracts of selected Trametes species were
determined for Candida albicans (BEOFB 811m), C. krusei (BEOFB 821m), C. parapsilosis
(BEOFB 831m), Aspergillus glaucus (BEOFB 301m), A. flavus (BEOFB 221m) and A. fumigatus
(BEOFB 232m). Cultures of the micromycetes were provided by the Institute of Public Health
of Serbia (Belgrade, Serbia) and maintained on malt agar medium at 4 ˚C in the culture collec-
tion of the Institute of Botany, Faculty of Biology, University of Belgrade.
The tested micromycetes were cultivated on Sabouraud dextrose agar (SDA) at temperature
of 37 ˚C for 21 days. Cell/spore suspensions were prepared by washing agar surface with sterile
0.9% saline enriched with 0.1% Tween-a 80 (v/v). The obtained suspensions were squeezed
through double sterile gauze and mixed at vortex and thereafter cell/spore number was defined
by hemocytometer. Level of turbidity was determined spectrophotometrically at 530 nm and
cell/spore number was adjusted to 106 CFU/mL with sterile saline [14].
DMSO extracts of fruiting bodies and mycelia were sterilized by filtration through What-
man No. 4 filter paper and 0.2 μm membrane filter. Antifungal potentials of extracts were
determined by microdilution method, using 96-well microtiter plates [15]. Series of double
extract dilutions (from 32.0 to 0.5 mg/mL) were analyzed. Each well contained Sabouraud
Table 1. Geographic origin of studied Trametes species.
Species Code of strain Origin of strain Names of the locations Geographic coordinates
Trametes gibbosa (Pers.) Fr. BEOFB310 Suva Mt., Serbia Devojački grob N 43˚19ˈ89.27˝, E 22˚14ˈ25.68˝
Trametes hirsuta (Wulf.:Fr.) Pil. BEOFB301 Suva Mt., Serbia Kraljev put N 43˚20ˈ41.77˝, E 22˚13ˈ76.76˝
Trametes versicolor (L.:Fr.) Lloyd BEOFB321 Suva Mt., Serbia Kraljev put N 43˚20ˈ63.89˝, E 22˚13ˈ53.58˝
https://doi.org/10.1371/journal.pone.0203064.t001
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dextrose broth (SDB), cell/spore suspension and extract of a defined concentration. Oxido-
reduction indicator of micromycete growth, resazurin (10.0 μL), was added to the mixture
after 24 hours of incubation at 37 ˚C and cultivation was continued for next 48 hours. Mixture
without extract was used as a negative control, while a positive control contained commercial
antimycotic, ketoconazole, instead extract. The tested ketoconazole concentrations were ran-
ged from 0.031 to 0.002 mg/mL (series of double dilutions). The effect of 5% DMSO on cell
growth and spore germination was also analyzed by its addition to the mixture instead SDB.
The lowest extract concentration without visible mycelium growth was defined as the minimal
inhibitory concentration (MIC), and that without growth after reinoculation of 2.0 μL of the
mixture on SDA as the minimal fungicidal concentration (MFC) [16].
Determination of antioxidative activity
Antioxidative activities of basidiocarp and mycelium extracts of the studied species were deter-
mined by two methods, ABTS and FRAP tests.
ABTS test is based on measuring the level of ABTS stock solution colour change [17].The
initial solution of ABTS cation radicals was prepared by dissolution of 9.0 μg ABTS in 2.5 mL
dH2O and addition of 44.0 μL 140 mM potassium persulphate (K2S2O8) solution, 12 to 16
hours before experiment beginning, while the stock solution was prepared immediately prior
to measurement by dilution of the initial solution with dH2O and adjustment of solution
absorbance on 0.700 ± 0.020 at 734 nm. The reaction mixture (1500.0 μL of the ABTS stock
solution and 15.0 μL of extract of concentration of 1.0 mg/mL) was incubated at room temper-
ature for 4 min and absorbance change was measured spectrophotometrically at 734 nm. Dis-
tilled water was used as a blank. Extract concentration required for ABTS+ reduction,
equivalent to reduction of 1.0 mg/mL ascorbic acid (AAEC), was determined using equation
of calibration curve for ascorbic acid. EC50 value (mg extract/mL) presents effective extract
concentration that scavenging 50% ABTS cation radicals and it is obtained by linear regression
analysis.
FRAP test presents measuring the level of change of ferric tripyridyl triazine (Fe(III)
(TPTZ)2) complex colour during reduction of ferrous form (Fe (II)-TPTZ) which has an
intense blue colour [18]. The solution of FRAP reagent (300 mM acetic buffer (pH 3.6), 10
mM solution of 2,4,6-Tri(2-pyridyl)-s-triazine(TPTZ) in 40 mM HCl, 20 mM FeCl3 × 6H2O)
was prepared immediately prior to measurement and heated at 37 ˚C. Absorbance of the reac-
tion mixture (3000.0 μL of FRAP reagent and 100.0 μL of extract) was measured spectrophoto-
metrically at 593 nm after 4 min of incubation at 37 ˚C. The mixture which contained dH2O
instead extract was used as a negative control and FRAP reagent as a blank. Antioxidative
activity was defined using equation of calibration curve for FeSO4 × 7H2O according to the
formula:
F ðmMÞ ¼ ðS=change of standard absorbanceÞ  FRAP values for 1 mM of standard
F–equivalent of reduced Fe2+, S –change of sample absorbance, standard–L-ascorbic acid. The
results were presented as equivalent of reduced Fe2+expressed in mM.
Determination of cytotoxic activity
Human cervix adenocarcinoma (HeLa), human colon carcinoma (LS174) and human lung ade-
nocarcinoma (A549) cell lines, obtained from the American Type Culture Collection (ATCC),
were used in the study. These cancer cell lines were maintained in the recommended Roswell
Park Memorial Institute (RPMI) 1640 medium supplemented with 100.0 g/L heat-inactivated
(56 ˚C) fetal bovine serum (FBS), 3.0 mM L-glutamine, 100.0 mg/mL streptomycin, 100 IU/mL
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penicillin, and 25.0 mM 4-(2 hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and pH
7.2 adjusted with bicarbonate solution. Cells were grown in a humidified atmosphere of 95%
air/5% CO2 (v/v) at 37 ˚C.
Stock solution of extracts (100.0 mg/mL), prepared in 50.0 g/LDMSO, was dissolved in
enriched RPMI 1640 medium to the required working concentrations. Inoculation of 100.0 μL
of medium per microtiter plate well was performed with 2000 neoplastic HeLa, 7000 LS174 or
5000 A549 cells. MRC5 cell line of human fetal fibroblast (5000 cells per wall) was used for
assessment of the potential of selective action of tested extracts on cancer cell lines. RPMI 1640
medium was used as a blank. After 24 hours of incubation and cell adhesion, 50.0 μL of extract,
at the concentrations of 200.0, 100.0, 50.0, 25.0 and 12.5 μg/mL, was added per well, while the
same amount of fresh medium was added in the blanks and wells with control cells. Cell cul-
tures were incubated at 37 ˚C for 72 hours.
Effects of extracts on survival of cell lines were determined by microculture tetrazolium test
(MTT test), i.e. by measuring of tetrazolium salt reduction to insoluble purple coloured forma-
zan in living cells [19, 20]. After 72-hour-old incubation, 20.0 μL of MTT solution [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in phosphate-buffering saline] at
the concentration of 5.0 mg/mL was added to each wall. The samples were incubated at 37 ˚C
in humidified atmosphere of 95% air/5% CO2 (v/v) for 4 hours and thereafter 100.0 μL of 10%
sodium dodecylsulphate (SDS) dissolved in 0.01 M HCl was added in order to dissolve the
insoluble formazan. After 24 hours, cell growth inhibition rate was determined by ELISA
microplate reader at 575 nm and calculated according to the formula:
Cell growth inhibition rate ð%Þ ¼ ðAc   AsÞ =Ac  100
Ac−absorbance of the control, As−absorbance of sample.
IC50value was defined as the concentration of the extract inhibiting cell survival by 50%
compared with a negative control (DMSO instead extract). Commercial cytostatics, cis-dia-
mminedichloroplatinum (cis-DDP) and doxorubicin were used as a positive control.
Antineurodegenerative activity assays
Determination of acetylcholinesterase inhibitory activity. Acetylcholinesterase (AChE)
activity inhibition rate was determined spectrophotometrically using 96-well microtiter plates
by method of Ellman et al. [21]. The reaction mixture (140.0 μL of 0.1 mM sodium phosphate
buffer (pH 8.0), 20.0 μL of 5,50-dithiobis(2-nitrobenzoic acid) (DTNB), 20.0 μL of extract,
20.0 μL of AChE) was incubated at 25 ˚C for 15 min. Reaction was initiated by adding of
10.0 μL of acetylthiocholine iodide which hydrolysis was accompanied by a change of absor-
bance at 412 nm due to transformation of DTNB to yellow 5-thio-2-nitrobenzoate anion
(TNB2-) in the reaction catalyzed by AChE, 15 min after initiation. Mixture of 5% DMSO and
sodium phosphate buffer (pH 8.0) was used as a blank. AChE activity inhibition rate was deter-
mined according to the formula:
AChE activity inhibition rate ð%Þ ¼ ½ðE   SÞ=E  100
E–enzyme activity without extract, S–enzyme activity with extract.
The obtained values were compared with commercial inhibitor of AChE, galantamine.
Determination of tyrosinase inhibitory activity. Tyrosinase activity inhibition rate was
determined spectrophotometrically using 96-well microtiter plates by method of Likhitwitaya-
wuid and Sritularak [22]. The reaction mixture (80.0 μL of 66.7 mM phosphate buffer (pH
6.8), 40.0 μL of extract, 40.0 μL of tyrosinase (46 U/L) dissolved in phosphate buffer) was incu-
bated at 23 ˚C for 10 min and thereafter 40.0 μL of 2.5 mM L-DOPA was added. Absorbance
Trametes spp. extracts as new biologically active agents
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was measured after 30 min of incubation at 475 nm. Tyrosinase activity inhibition rate was
determined according to the formula:
Tyrosinase activity inhibition rate ð%Þ ¼ ½ððA   BÞ   ðC   DÞÞ=ðA   BÞ  100
A–absorbance of tyrosinase in phosphate buffer, B–absorbance of phosphate buffer, C–absor-
bance of the reaction mixture, D–absorbance of extract in phosphate buffer.
Determination of phenol and flavonoid contents
Contents of soluble phenolic compounds in the extracts of fruiting bodies and mycelia of the
studied species were determined using Folin-Ciocalteu reagent and gallic acid as standards
[23]. The reaction mixture (mixture of 1000.0 μL of 10% Folin-Ciocalteu reagent and 200.0 μL
of sample of concentration of 1.0 mg/mL was incubated for 6 min in dark and thereafter
enriched with 800.0 μL of Na2CO3) was incubated on rotary shaker (100 rpm) in dark at room
temperature for 2 hours. Absorbance was measured spectrophotometrically at 740 nm. The
mixture without extract was used as a blank. Total phenol content was presented as gallic acid
equivalent (GAE) per mg of dried extract using equation of calibration curve for GAE.
Total flavonoid contents in extracts were determined by method of Park et al. [24]. The
reaction mixture (1000.0 μL of extract of concentration of 1.0 mg/mL, 4100.0 μL of 80% etha-
nol, 100.0 μL of 10% Al(NO3)3 × 9H2O and 100.0 μL of 1.0 M water solution of potassium ace-
tate) was incubated in dark on a rotary shaker (100 rpm) and room temperature for 40 min
and thereafter absorbance was measured at 415 nm. The mixture which contained ethanol
instead extract was used as a blank. Total flavonoid content was presented as μg of quercetin
equivalent (QE) per mg of dried extract using equation of calibration curve for QE.
1H NMR spectroscopy
All NMR spectra were measured on Bruker (Billerica, MA, USA) AVANCE III spectrometer
(500.26 MHz for 1H nuclei), using 5 mm broad-band probehead. Samples were dissolved in
standard buffer solution 90 mM KH2PO4 in D2O (pH 6.0) and spectra were obtained at 298 K.
Statistical analysis
The assays were carried out in five replicates and results are expressed as mean ± standard error.
One-way analysis of variance (ANOVA) and Tukey‘s HSD post-hoc test were performed to test
any significant differences among means. Statistical significance was declared at P< 0.01. All sta-
tistical analyses were done using software STATISTICA, version 6.0 (StatSoft, Inc., Tulsa, USA).
Results
Extraction yield
Yields of extractions of fruiting bodies and mycelia of Trametes gibbosa BEOFB 310, T. hirsuta
BEOFB 301 and T. versicolor BEOFB 321 in 96% ethanol differed statistically as among species
Table 2. Yields (%) of selected Trametes spp. basidiocarp and mycelium extractions.
Species Basidiocarps Mycelium
Trametes gibbosa 2.20 ± 0.02 Ca 34.60 ± 0.27 A
Trametes hirsuta 2.85 ± 0.08 B 12.00 ± 0.19 B
Trametes versicolor 6.67 ± 0.07 A 8.00 ± 0.12 C
a Means with different letters within a column are significantly different(P<0.01)
https://doi.org/10.1371/journal.pone.0203064.t002
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as between somatic and reproductive phases (P<0.01). Yield of mycelium extraction was
higher than basidiocarp one and it was ranged from 8.00 ± 0.27% in T. versicolor to
34.60 ± 0.27% in T. gibbosa. Contrary to the results for mycelium, the highest level of fruiting
body extraction was noted in T. versicolor (6.67 ± 0.07%) and the lowest in T. gibbosa
(2.20 ± 0.02%) (Table 2).
Antifungal activity
Levels of sensitivity of 6 human pathogens to ethanolic extracts of basidiocarps and mycelia of
the tested species of the genus Trametes were different (Table 3). Mycelial extracts showed
higher antifungal potential in comparison with basidiocarp ones. Thus T. hirsuta mycelium
extract inhibited the growth of Candida krusei at concentration of only 4.0 mg/mL and at the
concentration of 32.0 mg/mL growth of other tested species. This extract at concentration of
32.0 mg/mL had also fungicidal effect on Aspergillus glaucus. Basidiocarps extracts inhibited
growth of a small number of micromycetes and T. hirsuta extract had the highest capacity
among tested species because it inhibited C. parapsilosis growth at concentration of 16.0 mg/
mL. Based on MIC and MFC values analyzed extracts showed significantly weaker antifungal
potential in comparison with commercial antimycotic ketoconazole which MIC was ranged
between 0.0078 mg/mL (Candida albicans, C. krusei, C. parapsilosis, Aspergillus flavus,A. fumi-
gatus) and 0.0156 mg/mL (A. glaucus) and MFC from 0.0078 mg/mL (A. flavus) to 0.0313 mg/
mL (A. glaucus). Antifungal potential of tested Trametes species was decreased by the next
order: T. hirsuta > T. versicolor > T. gibbosa.
Species of the genus Candida were more sensitive to tested extracts then species of the
genus Aspergillus and sensitivity was decreased by the order: C. parapsilosis > C. albicans > A.
glaucus> C. krusei> A. fumigates > A. flavus. However, mycelial extracts of T. gibbosa (at sub-
inhibitory concentrations) and T. hirsuta (at concentrations higher than 2.0 mg/mL) caused
conidium demelanisation in the most resistant A. flavus.
Antioxidative activity
Extracts of fruiting bodies and mycelia of selected Tramates species showed significant antioxi-
dative potentials which varied depending on species and material used for extraction. Basidio-
carp extracts had significantly higher capacity than mycelium ones (P<0.01), but lower in
comparison with commercial antioxidant, L-ascorbic acid (Table 4).
Extracts of T. versicolor fruiting bodies and mycelium had the highest ability of ABTS radi-
cal scavenging and Fe2+reduction. EC50 of basidiocarp and mycelium extracts in the radical
Table 3. Antifungal activities of ethanolic extracts of selected Trametes spp. basidiocarps (B) and mycelia (M) and commercial antimycotic.
Species Trametes gibbosa Trametes hirsuta Trametes versicolor Ketoconazole
MIC
(mg mL-1)
MFC
(mg mL-1)
MIC
(mg mL-1)
MFC
(mg mL-1)
MIC
(mg mL-1)
MFC
(mg mL-1)
MIC
(mg mL-1)
MFC
(mg mL-1)
B M B M B M B M B M B M
Candida albicans (BEOFB 811m) nd 32.0 nd nd 32.0 32.0 nd nd nd 32.0 nd nd 0.0078 0.0156
Candida krusei (BEOFB 821m) nd nd nd nd nd 4.0 nd nd nd 8.0 nd nd 0.0078 0.0156
Candida parapsilosis (BEOFB 831m) 32.0 32.0 nd nd 16.0 32.0 nd nd nd nd nd nd 0.0078 0.0156
Aspergillus glaucus (BEOFB 301m) nd 32.0 nd nd nd 32.0 nd 32.0 nd 32.0 nd nd 0.0156 0.0313
Aspergillus flavus (BEOFB 221m) nd 32.0 nd nd nd nd nd nd nd nd nd nd 0.0078 0.0078
Aspergillus fumigatus (BEOFB 232m) nd 32.0 nd nd nd 32.0 nd nd nd nd nd nd 0.0078 0.0156
nd–not detected
https://doi.org/10.1371/journal.pone.0203064.t003
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neutralization were 8.46 ± 0.49 mg/mL and 20.00 ± 1.57 mg/mL, respectively, while amounts
of reduced Fe2+ were 0.037 ± 0.007 and 0.025 ± 0.000 mM, respectively. Extracts of T. gibbosa
mycelium had the lowest antioxidative capacity, i.e. EC50 value in ABTS
+ scavenging was
31.43 ± 0.83 mg/mL and amount of reduced Fe2+ was only 0.011 ± 0.001 mM (Table 4).
Studies of phenol and flavonoid contents in the extracts of selected Trametes species showed
that they were present both in fruiting bodies and mycelia (Table 5). Among the tested species,
fruiting bodies and mycelium of T. gibbosa were the richest with phenols (18.21 ± 0.30 and
14.79 ± 0.57 μg GAE/mg, respectively) and flavonoids (2.85 ± 0.06 and 3.46 ± 0.08 μg QE/mg,
respectively) contrary to T. hirsuta extracts where amounts of phenol were less in even 50.85%
and 16.09%, respectively, and flavonoid in 35.09% and 31.79%. Since very low correlation
between contents of the compounds and radical neutralization levels was found (R2 values for
fruiting body phenols and flavonoids were 0.19 and 0.15, respectively, and for mycelium ones
0.01 and 0.00, respectively), it was concluded that they were not the main or the only carriers
of antioxidative potentials of the species.
Cytotoxic activity
Extracts of studied Trametes species showed lower cytotoxic effects on tested cancer cell lines
in comparison with commercial cytostatics, cis-DDP and doxorubicin, which were used as a
positive control (Table 6). Mycelium extracts had stronger cytotoxic effects than basidiocarp
ones. Comparing studied species, it was shown that T. hirsuta was a species with the highest
cytotoxic potential contrary to T. gibbosa which basidiocarp and mycelium extracts were the
Table 4. Antioxidative activities of ethanolic extracts of selected Trametes spp. basidiocarps and mycelia and commercial antioxidant.
Species Extract EC50
[mg mL-1]
Equivalent of reduced Fe2+ [mM]
ABTS FRAP
Trametes gibbosa basidiocarps 14.67 ± 0.93 Ea 0.015 ± 0.001 D
mycelium 31.43 ± 0.83 A 0.011 ± 0.001 E
Trametes hirsuta basidiocarps 18.33 ± 1.41 D 0.013 ± 0.003 D
mycelium 27.50 ± 0.42 B 0.016 ± 0.004 D
Trametes versicolor basidiocarps 8.46 ± 0.49 F 0.037 ± 0.007 B
mycelium 20.00 ± 1.57 C 0.025 ± 0.00 C
L-ascorbic acid 0.247 ± 0.012 G 2.282 ± 0.023 A
a Means with different letters within a column are significantly different (P<0.01)
https://doi.org/10.1371/journal.pone.0203064.t004
Table 5. Phenol and flavonoid contents in ethanolic extracts of selected Trametes spp. basidiocarps and mycelia.
Species Extract Phenol content
(μg GAE mg-1 of dried extract)
Flavonoid content
(μg QE mg-1 of dried extract)
Trametes gibbosa basidiocarps 18.21 ± 0.30 Aa 2.85 ± 0.06 C
mycelium 14.79 ± 0.57 B 3.49 ± 0.08 A
Trametes hirsuta basidiocarps 8.95 ± 0.30 D 1.85 ± 0.00 E
mycelium 12.41 ± 0.24 C 2.36 ± 0.03 D
Trametes versicolor basidiocarps 14.18 ± 0.30 B 1.51 ± 0.03 F
mycelium 14.51 ± 0.27 B 3.21 ± 0.11 B
a Means with different letters within a column are significantly different (P<0.01)
https://doi.org/10.1371/journal.pone.0203064.t005
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weakest anticancer agents. Screening of IC50 values showed that they were ranged from
21.01 ± 1.95 μg/mL for T. hirsuta mycelium extract against HeLa cells to over 200.00 μg/mL
for the same extract against other tested cell lines and for T. versicolor basidiocarp extract
against LS174, A549 and MRC5, as well as that HeLa cells were the most sensitive to tested
extracts and commercial cytostatics (Table 6).
Potential of acetylcholinesterase and tyrosinase inhibition
Basidiocarp and mycelium extracts of the studied species showed significant potentials of inhi-
bition of acetylcholinesterase and tyrosinase activities in comparison with synthetic inhibitors,
galantamine and kojic acid, respectively (Fig 1A and 1B). Extents of AChE activity inhibition
were ranged between 24.7 ± 0.6% and 28.9 ± 0.8%, and statistically significant differences
between basidiocarp and mycelium extracts were not noted except in the case of T. versicolor
where mycelium extract was significantly better inhibitor (P<0.05). T. versicolor mycelium
extract was the most effective, namely it inhibited AChE activity in 28.9 ± 0.8% which was
almost double less than commercial inhibitor galantamine (57.1 ± 1.7%) (Fig 1A).
In the case of tyrosinase, high extents of activity inhibition (ranged from 49.5 ± 4.2% to
92.7 ± 3.9%) were noted for majority of extracts, except for T. gibbosa basidiocarp one where
inhibition was significantly lower, only 21.9 ± 1.0% (Fig 1B). T. gibbosa was also unique species
according to statistically significant difference between basidiocarp and mycelium extracts in
levels of tyrosinase activity inhibition (P<0.001), which was not observed in other two studied
species. In comparison with kojic acid as a synthetic inhibitor of tyrosinase activity which
inhibited 51.8 ± 2.5% of the enzyme at concentration of 100.0 μg/mL, T. versicolor extracts
were significantly better inhibitors of the enzyme (Fig 1B).
1H NMR spectroscopy
In the present study, the ethanol extracts of mycelia and basidiocarps of studied Trametes spe-
cies were analyzed by 1H NMR spectroscopy. The obtained NMR spectra of extracts of all
examined species showed the presence of metabolic variations between mycelia and basidio-
carps (Fig 2). The major differences in NMR spectra were in the region δ6.5–8.5ppm (S1 Fig).
This chemical shifts reported for different polyphenols. Differentiations in a region of δ0.8–
1.3 ppm, were from methyl groups of triterpenes. Sugars were present in all extracts i.e., signals
around 5 ppm are from anomer protons of sugars and in the area between δ3.0–4.5 ppm are
Table 6. Cytotoxic activities of selected Trametes spp. basidiocarp and mycelium extracts and commercial cytostatics.
Species Extract IC50 [μg mL-1]
HeLa LS174 A549 MRC5
Trametes gibbosa basidiocarps 193.53 ± 8.91 Ba >200.00 A >200.00 A >200.00 A
mycelium >200.00 A >200.00 A >200.00 A >200.00 A
Trametes hirsuta basidiocarps 116.13 ± 3.14 C 158.46 ± 37.15 B 177.66 ± 20.17 B 175.70 ± 1.45 B
mycelium 21.01 ± 1.95 E 45.75 ± 0.02 D 57.94 ± 5.08 C 145.17 ± 6.48 C
Trametes versicolor basidiocarps 168.54 ± 28.90 B >200.00 A >200.00 A >200.00 A
mycelium 42.40 ± 0.74 D 86.12 ± 12.34 C 65.57 ± 7.75 C 77.37 ± 0.82 D
cis-DDP 2.10 ± 0.20 F 5.54 ± 1.03 E 11.92 ± 2.19 D 14.44 ± 1.90 E
Doxorubicin 0.62 ± 0.30 G 3.78 ± 0.49 F 0.24 ± 0.02 E 0.46 ± 0.18 F
a Means with different letters within a column are significantly different (P<0.01)
Commercial cytostatic
https://doi.org/10.1371/journal.pone.0203064.t006
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Fig 1. Potential of basidiocarp and mycelium extracts of selected Trametes species and commercial inhibitors to
inhibit activities of acetylcholinesterase (A) and tyrosinase (B) at concentration of 100.0 μg/mL.
https://doi.org/10.1371/journal.pone.0203064.g001
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signals from sugars and aliphatic amino acids (Fig 2). Results indicated that mycelium extract
of T. hirsuta was the richest with metabolites as there were signals of triterpenes, sugars and
polyphenols (Fig 3). Correlating to this, ethanol extract of T. hirsuta mycelium shows the best
activities in all tests conducted, except in tyrosinase inhibition. On the other hand, in basidio-
carp extract of T. hirsuta the main components were mostly sugars and they have very low
activities. The NMR profile of T. versicolor mycelium is similar to T. hirsuta and has similar
test results. T. gibbosa has the poorer 1H NMR spectra profile for both mycelium and basidio-
carp extracts. Dominant signals came from sugars (δ3.0–4.5 ppm). This extract shows less
activity in all tests, and NMR profiles are compatible with that result.
Fig 2. The full 1H NMR spectra of ethanol extracts of selected Trametes species. T. gibbosa basidiocarp (TGB), T. gibbosa mycelium (TGM), T.
hirsuta basidiocarp (THB), T. hirsuta mycelium (THM), T. versicolor basidiocarp (TVB), T. versicolor mycelium (TVM).
https://doi.org/10.1371/journal.pone.0203064.g002
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Discussion
The previous results showed that biomass extractability depends on species, strain and solvent
[25, 26, 27]. Thus Ren et al. [26] demonstrated that yield of Trametes gibbosa basidiocarp
extraction in petroleum ether, ethyl acetate and methanol was rather different. Methanol was
also good solvent for T. versicolor fruiting body extraction and extraction yields were ranged
between 4.10% and 9.16% [25, 27]. Based on numerous results it can be concluded that yield of
extraction is higher in alcohols than in other solvents, as well as that methanol is better solvent
than 96% ethanol.
Numerous studies showed that various basidiocarp and mycelium extracts of the Trametes
species possess antifungal properties [28, 29, 30]. Using disc-diffusion method, Yamac¸ and Bil-
gili [28] reported that acetone extract of T. versicolor fruiting bodies was highly active against
Saccharomyces cerevisiae but without any effect on C. albicans. Contrary to acetone extract,
ethyl acetate and dichloromethane extracts of these species basidiocarps at the same concentra-
tion had no antifungal effect. Later, using microdilution method, Sivaprakasam et al. [29] and
Hleba et al. [30] showed that T. versicolor fruiting body extract inhibited the growth of C. albi-
cans (MIC was higher than 1.0 mg/mL), that A. flavus,A. fumigatus and A. niger were slightly
sensitive to methanolic and aqueous extracts of T. hirsuta basidiocarps, and that methanolic
extracts had higher antifungal potential compared with aqueous but still significantly weaker
in comparison with commercial antimycotic.
Fig 3. 1H NMR spectrum of Trametes hirsuta mycelium extract with labeled peaks from appropriate group of compounds.
https://doi.org/10.1371/journal.pone.0203064.g003
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Although previous studies showed that phenolic compounds presented in fruiting bodies
and mycelia of the Trametes species are the main carriers of antifungal activity, terpenoids,
polysaccharides PSK and PSP and cinnamic acid also have this role [7, 10, 11]. Antifungal
activities of polyphenols depend on their chemical structure and polarity, i.e. lack of polar
groups increases the lipophilicity and facilitates diffusion through the cell membrane [31].
According to Daglia [32] this activity of phenol compounds is based on presence of highly
reactive hydroxyl groups as well as parts which have high affinity for binding for proteins that
primarily inhibit telomerase and lipoxygenase and interactions with signalling transduction
pathways of membrane receptors. However, Cowan [33] emphasized that phenol antifungal
activity can also be realized by inhibition of oxidative phosphorylation though sulfhydryl
groups as well as various nonspecific interactions.
Morpho-physiological changes, including demelanization of reproductive structures, in the
species of the genus Aspergillus exposed to the effects of individual plant extract compounds as
well as macromycete extracts were observed by De Billerbeck et al. [34] and Souza et al. [35].
Mossier et al. [36] pointed out that conidia depigmentation can be attributed to the effects of
phenolic compounds present in extracts of numerous macromycetes which inhibit melanin
synthesis. Melanin is able to absorb 50–75% UV-light and neutralize free radicals generated by
action of host macrophags and neutrophils that contribute to spore resistance and survival as
well as to virulence of pathogen micromycetes, while demelanization can significantly decrease
their extent of pathogenicity [37, 38]. This property can be important, especially in the case of
the Aspergillus species, because some of them cause serious mycosis and mycotoxicosis in
human and animals [39].
Species of the genus Trametes are also characterized by significant antioxidative potential
[6, 40, 41]. Kamiyama et al. [41] reported that, depending on solvent, extract of T. versicolor
fruiting bodies can neutralise up to 50% DPPH•, and Johnsy and Kaviyarasana [40] that
methanolic extract of T. gibbosa basidiocarps reduced even 91.5% of these radicals. Ethanolic
extracts of T. gibbosa BEOFB 310, T. hirsuta BEOFB 301 and T. versicolor BEOFB 321 had
slightly lower capacity of DPPH radical scavenging [42] but higher in comparison with ethano-
lic extracts of T. hirsuta strain studied by Sheikh et al. [6]. Additionally, it was shown for sev-
eral mushroom species to possess moderate or even high capacity to neutralise ABTS radicals
or to have ferric ion reducing power [43, 44]. ABTS radical scavenging for methanolic extract
was ranged from 20% to 90% and for T. consors was approximately 47% [43]. Results presented
in the study of Gan et al. [44] demonstrated that ethanolic and aqueous extracts of Agaricus
bisporus and A. brasiliensis could reduce ferric ions producing the Fe2+ equivalents in the
amounts ranged from 0.084 to 0.187 mM, which was higher reducing power comparing to the
studied Trametes species. It was previously shown that phenols are essential for free radical
scavenging in fungi due to the presence of hydroxyl groups which have role of neutralizers,
metal chelators and hydrogen donors [45]. These compounds are found in fruiting bodies and
mycelia of nearly all macromycetes and their amounts vary from species to species with signifi-
cantly higher content in basidiocarps [46]. However, comparing the results obtained for
DPPH• scavenging by T. gibbosa BEOFB 310 [42] and strain studied by Johnsy and Kaviyara-
sana [40] it can be concluded that phenols are not the only carriers of antioxidative activity.
Namely, content of phenols in T. gibbosa BEOFB 310 basidiocarp extract which scavenged
63.5% of DPPH radicals was only 15.7% lower than in the extract of another strain which
reduced even 91.5% of the radicals. In the case of flavonoids, concentration in T. gibbosa
BEOFB 310 was about 92% higher than in another strain and this significant difference can be
attributed to either various polarity of solvents or different capacity of their synthesis.
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Although the results demonstrated that in most cases cytotoxic effects of extracts were
weaker on control cell line than on cancer cells, only T. hirsuta mycelium extract showed satis-
factory level of selectivity to tested cancer cell lines.
Numerous searches showed that extracts as well as compounds isolated from various spe-
cies of the genus Trametes possess significant cytotoxic potential [8, 26, 47, 48]. Abilities of
ethanolic extracts of T. hirsuta and T. versicolor fruiting bodies and mycelia to suppress pro-
liferation of HeLa, LS174 and A549 cell lines in vitro are in accordance with the results
obtained by Lau et al. [47] and Janjusˇević et al. [49] for ethanolic extract of T. versicolor basi-
diocarps which IC50 values for promyeloid leukaemia (HL-60 and NB-4), Burkitt lymphoma
(Raji), human breast adenocarcinoma (MCF-7) and liver hepatocellular carcinoma
(Hep2G) cell lines were ranged between 123.5 and 269.3 μg/mL. In comparison with the
results of these authors, cytotoxic activity of ethanolic extract of T. versicolor BEOFB 321
mycelium was significantly higher, considering that IC50 values for all studied cell lines
were less than 100.0 μg/mL. Likewise, based on the results of these authors as well as Harhaji
et al. [8] for mouse B16 melanoma cell line it can be assumed that proliferation inhibition
and apoptosis induction are mechanisms of cytotoxic activities of extracts. Hsieh et al. [50]
showed that antiproliferative effects of T. versicolor ethanolic extracts are based on arrest of
cell cycle in G0/G1 phase and Harhaji et al. [8] reported that fruiting body methanolic
extract of this species arrests cycle of melanoma B16 cells in S and G2/M phase. Cytotoxic
activity of extracts of the studied species can be attributed to proteoglucans, terpenoids and
phenol compounds which are soluble in ethanol and that are found in basidiocarp and
mycelium extracts of Trametes species [8, 26, 51]. Considering that compounds of Trametes
spp. extracts showed significant positive results in clinical trials in patients suffering from
different cancers [3, 7] and that cytotoxic effect is the feature of majority of antitumor drags
[8], it can be said that potentials of studied species, especially selectivity of T. hirsuta myce-
lium extract in comparison with the control cell line, are from great importance for future
researches of possible use in the cancer treatment.
Selected species of the genus Trametes were for the first time tested in terms of inhibition of
AChE and tyrosinase activities, which was preliminary reported by Knezˇević et al. [52]. Previ-
ous searches showed that extracts of few fungal species can contain compounds which inhibit
AChE activity [53, 54]. This activity in mushrooms is attributed to terpenoids and alkaloids
which inactivate AChE by binding for active centre or peripheral binding sites [53, 55]. In
comparison with AChE activity inhibition rate, which was obtained by El-Hadi et al. [56] for
Emericella unguis extracts (80%, at concentration of 200.0 μg/mL), inhibition level of extracts
of selected Trametes species, at concentration of 100.0 μg/mL, can be considered significant.
Extracts of these species were shown as significantly stronger inhibitors of tyrosinase activity
than Aspergillus sydowii extracts (36%, at concentration of 200.00 μg/mL) and commercial
inhibitor, kojic acid [57]. According to Şenol et al. [58], this higher potential of tested extracts
to inhibit activities of AChE and tyrosinase in comparison with individual compounds can be
attributed to a synergistic interaction of numerous compounds of the crude extracts.
Conclusion
According to the presented results, extracts of Trametes gibbosa, T. hirsuta and T. versicolor
have significant medicinal potentials based on several groups of biologically active compounds
and their synergistic effects. The present study gave a novel approach in complementary strate-
gies for therapies of cancers and neurodegenerative disorders. Further studies should go
towards isolation, characterization and testing of individual active compounds of the extracts
with the aim of obtaining new drugs and creation of successful therapies.
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Supporting information
S1 Fig. 1H NMR spectra of ethanol extracts of selected Trametes species in area from 5 to
10 ppm. T. gibbosa basidiocarp (TGB), T. gibbosa mycelium (TGM), T. hirsuta basidiocarp
(THB), T. hirsuta mycelium (THM), T. versicolor basidiocarp (TVB), T. versicolor mycelium
(TVM).
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